• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Selected studies of daunorubicin in adult acute nonlymphocytic leukemia.

作者信息

Wiernik P H

出版信息

Semin Oncol. 1984 Dec;11(4 Suppl 3):12-4.

PMID:6390686
Abstract
摘要

相似文献

1
Selected studies of daunorubicin in adult acute nonlymphocytic leukemia.柔红霉素治疗成人急性非淋巴细胞白血病的相关研究精选。
Semin Oncol. 1984 Dec;11(4 Suppl 3):12-4.
2
Clinical pharmacology of daunorubicin in patients with acute leukemia.
Semin Oncol. 1984 Dec;11(4 Suppl 3):2-11.
3
Uptake and metabolism of daunorubicin by human myelocytic cells.
Cancer Chemother Pharmacol. 1985;15(1):35-9. doi: 10.1007/BF00257291.
4
Daunorubicin reductase activity in human normal lymphocytes, myeloblasts and leukemic cell lines.
Eur J Cancer Clin Oncol. 1985 Oct;21(10):1209-13. doi: 10.1016/0277-5379(85)90017-3.
5
Daunorubicin reduction mediated by aldehyde and ketone reductases.
Xenobiotica. 1981 Feb;11(2):131-6. doi: 10.3109/00498258109045283.
6
Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
Cancer Treat Rep. 1981;65 Suppl 4:67-71.
7
Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.采用柔红霉素和阿糖胞苷治疗成人急性非淋巴细胞白血病
Cancer Treat Rep. 1977 Nov;61(8):1441-5.
8
Alterations in the expression of daunorubicin phase-I metabolising enzymes in different carcinoma cell lines.
Adv Exp Med Biol. 1999;463:545-51. doi: 10.1007/978-1-4615-4735-8_69.
9
High-dose daunorubicin therapy for acute nonlymphocytic leukemia: correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity.
Cancer. 1972 Dec;30(6):1419-27. doi: 10.1002/1097-0142(197212)30:6<1419::aid-cncr2820300602>3.0.co;2-i.
10
Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells.
Cancer Chemother Pharmacol. 1986;18(2):105-10. doi: 10.1007/BF00262277.

引用本文的文献

1
Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion.
Cancer Chemother Pharmacol. 1987;20(4):311-5. doi: 10.1007/BF00262582.